Top Markets
Coin of the day
Restart Life Sciences Corp. Restart Life Sciences Corp.

Restart Life Sciences Corp.

HEAL
Rank in Stocks #37250
Operating internationally through its various subsidiaries, Restart Life... Operating internationally through its various subsidiaries, Restart Life Sciences Corp. functions as a biotechnology firm. Its core endeavors include the creation of natural therapeutic remedies tailored for individuals with autism spectrum disorder, the development of health-promoting foods designed for comprehensive mind and body wellness, and the execution of a psilocybin clinical trial aimed at fragile X syndrome. Founded in 2004 and based in Vancouver, Canada, the company adopted its current name in November 2024, having previously been known as Nova Mentis Life Science Corp.
Share Price
$0.05137558
Last synced: 2026-08-13
Market Cap
$1.88M
Change (1 day)
0.00%
Change (1 year)
-11.66%
Country
CA
Trade Restart Life Sciences Corp. (HEAL)

Category

P/B ratio for Restart Life Sciences Corp. (HEAL)
P/B ratio as of 2026 TTM: 0
According to Restart Life Sciences Corp. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Restart Life Sciences Corp. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
6.3419 -
US
6.2413 -
NL
- -
CH
- -
KR
3.4612 -
BE